Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | UTHR | SMMT | ||
| Company | Neurocrine Bioscienc | United Therapeutic | Summit Therapeu ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 133.31 | 468.70 | 17.26 | ||
| High | 134.02 | 470.08 | 17.48 | ||
| Low | 131.36 | 461.45 | 17.02 | ||
| Latest | 132.39 | 464.93 | 17.04 | ||
| Change | -0.96 | -7.06 | -0.23 | ||
| % Change | -0.72% | -1.50% | -1.33% | ||
| Volume | 1,023,400 | 397,700 | 2,027,500 | ||
| 20-Day Average Volume | 1,119,945 | 430,660 | 2,640,295 | ||
| Previous Close | 133.35 | 471.99 | 17.27 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 139.61 | 494.76 | 17.87 | ||
| 20-Day Raw Stochastic | 6.32% | 5.94% | 19.59% | ||
| 20-Day Relative Strength | 38.24 | 41.77 | 45.09 | ||
| Weighted Alpha | -4.26 | +27.27 | -11.46 | ||
| Today's Opinion | 8% Sell | 56% Buy | 80% Sell | ||
| Previous Opinion | 8% Sell | 56% Buy | 80% Sell | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.50% since 01/09/26 | -3.79% since 01/09/26 | -13.41% since 01/09/26 | ||
| Low | 131.30 on 01/15/26 | 461.45 on 01/16/26 | 16.27 on 01/13/26 | ||
| High | 135.98 on 01/15/26 | 485.77 on 01/12/26 | 19.90 on 01/12/26 | ||
| 1-Month | |||||
| %Chg | -10.99% since 12/16/25 | -7.01% since 12/16/25 | -1.10% since 12/16/25 | ||
| Low | 131.30 on 01/15/26 | 461.45 on 01/16/26 | 16.27 on 01/13/26 | ||
| High | 150.47 on 12/17/25 | 519.99 on 12/23/25 | 20.20 on 01/09/26 | ||
| 3-Month | |||||
| %Chg | -3.73% since 10/16/25 | +7.45% since 10/16/25 | -22.44% since 10/16/25 | ||
| Low | 131.30 on 01/15/26 | 409.07 on 10/28/25 | 15.62 on 11/21/25 | ||
| High | 160.18 on 12/08/25 | 519.99 on 12/23/25 | 22.34 on 10/17/25 | ||
| 6-Month | |||||
| %Chg | -0.82% since 07/16/25 | +55.93% since 07/16/25 | -39.72% since 07/16/25 | ||
| Low | 123.67 on 08/08/25 | 272.12 on 07/31/25 | 15.62 on 11/21/25 | ||
| High | 160.18 on 12/08/25 | 519.99 on 12/23/25 | 30.98 on 08/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,200,078 | 20,018,486 | 13,140,398 | ||
| Shares Outstanding, K | 99,706 | 43,057 | 771,150 | ||
| Annual Sales | 2,355,300,000 | 2,877,400,000 | 0 | ||
| Annual Net Income | 341,300,000 | 1,195,100,000 | -221,320,000 | ||
| Last Quarter Sales | 794,900,000 | 799,500,000 | 0 | ||
| Last Quarter Net Income | 209,500,000 | 338,700,000 | -231,790,000 | ||
| 60-Month Beta | 0.28 | 0.84 | -1.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.04 on 10/28/25 | 7.16 on 10/29/25 | -0.31 on 10/20/25 | ||
| Latest Earnings Date | 02/05/26 | 02/25/26 | 02/23/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 31.90 | 17.89 | 0.00 | ||